vs

Side-by-side financial comparison of Pulmonx Corp (LUNG) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.

UNITY BANCORP INC is the larger business by last-quarter revenue ($35.3M vs $20.6M, roughly 1.7× Pulmonx Corp). UNITY BANCORP INC runs the higher net margin — 43.9% vs -66.3%, a 110.2% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs -8.7%). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs -0.5%).

Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.

Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.

LUNG vs UNTY — Head-to-Head

Bigger by revenue
UNTY
UNTY
1.7× larger
UNTY
$35.3M
$20.6M
LUNG
Growing faster (revenue YoY)
UNTY
UNTY
+32.8% gap
UNTY
24.2%
-8.7%
LUNG
Higher net margin
UNTY
UNTY
110.2% more per $
UNTY
43.9%
-66.3%
LUNG
Faster 2-yr revenue CAGR
UNTY
UNTY
Annualised
UNTY
17.5%
-0.5%
LUNG

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LUNG
LUNG
UNTY
UNTY
Revenue
$20.6M
$35.3M
Net Profit
$-13.7M
$15.5M
Gross Margin
77.9%
Operating Margin
-40.9%
55.8%
Net Margin
-66.3%
43.9%
Revenue YoY
-8.7%
24.2%
Net Profit YoY
5.5%
34.5%
EPS (diluted)
$-0.33
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LUNG
LUNG
UNTY
UNTY
Q1 26
$20.6M
Q4 25
$22.6M
$35.3M
Q3 25
$21.5M
$32.8M
Q2 25
$23.9M
$34.4M
Q1 25
$22.5M
$29.4M
Q4 24
$23.8M
$28.4M
Q3 24
$20.4M
$27.7M
Q2 24
$20.8M
$25.5M
Net Profit
LUNG
LUNG
UNTY
UNTY
Q1 26
$-13.7M
Q4 25
$-10.4M
$15.5M
Q3 25
$-14.0M
$14.4M
Q2 25
$-15.2M
$16.5M
Q1 25
$-14.4M
$11.6M
Q4 24
$-13.2M
$11.5M
Q3 24
$-14.1M
$10.9M
Q2 24
$-15.3M
$9.5M
Gross Margin
LUNG
LUNG
UNTY
UNTY
Q1 26
77.9%
Q4 25
77.6%
Q3 25
74.7%
Q2 25
72.1%
Q1 25
72.5%
Q4 24
74.0%
Q3 24
73.7%
Q2 24
73.7%
Operating Margin
LUNG
LUNG
UNTY
UNTY
Q1 26
-40.9%
Q4 25
-43.8%
55.8%
Q3 25
-66.9%
57.5%
Q2 25
-62.0%
62.6%
Q1 25
-64.6%
52.6%
Q4 24
-56.5%
51.0%
Q3 24
-69.3%
52.7%
Q2 24
-75.2%
49.3%
Net Margin
LUNG
LUNG
UNTY
UNTY
Q1 26
-66.3%
Q4 25
-46.1%
43.9%
Q3 25
-64.9%
43.8%
Q2 25
-63.6%
48.0%
Q1 25
-64.1%
39.5%
Q4 24
-55.4%
40.5%
Q3 24
-69.4%
39.4%
Q2 24
-73.7%
37.1%
EPS (diluted)
LUNG
LUNG
UNTY
UNTY
Q1 26
$-0.33
Q4 25
$-0.25
$1.52
Q3 25
$-0.34
$1.41
Q2 25
$-0.38
$1.61
Q1 25
$-0.36
$1.13
Q4 24
$-0.33
$1.13
Q3 24
$-0.36
$1.07
Q2 24
$-0.39
$0.92

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LUNG
LUNG
UNTY
UNTY
Cash + ST InvestmentsLiquidity on hand
$61.6M
Total DebtLower is stronger
$37.3M
Stockholders' EquityBook value
$45.8M
$345.6M
Total Assets
$120.0M
$3.0B
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LUNG
LUNG
UNTY
UNTY
Q1 26
$61.6M
Q4 25
$69.8M
Q3 25
$76.5M
Q2 25
$75.5M
Q1 25
$74.6M
Q4 24
$70.9M
Q3 24
$63.3M
Q2 24
$63.5M
Total Debt
LUNG
LUNG
UNTY
UNTY
Q1 26
$37.3M
Q4 25
$37.1M
Q3 25
$37.1M
Q2 25
$37.1M
Q1 25
$37.2M
Q4 24
$37.2M
$230.8M
Q3 24
$37.2M
Q2 24
$37.2M
Stockholders' Equity
LUNG
LUNG
UNTY
UNTY
Q1 26
$45.8M
Q4 25
$54.1M
$345.6M
Q3 25
$60.0M
$334.0M
Q2 25
$69.1M
$319.8M
Q1 25
$77.7M
$306.1M
Q4 24
$85.8M
$295.6M
Q3 24
$93.9M
$284.3M
Q2 24
$101.2M
$273.4M
Total Assets
LUNG
LUNG
UNTY
UNTY
Q1 26
$120.0M
Q4 25
$129.3M
$3.0B
Q3 25
$138.3M
$2.9B
Q2 25
$147.2M
$2.9B
Q1 25
$150.7M
$2.8B
Q4 24
$162.8M
$2.7B
Q3 24
$167.4M
$2.6B
Q2 24
$172.6M
$2.6B
Debt / Equity
LUNG
LUNG
UNTY
UNTY
Q1 26
0.82×
Q4 25
0.69×
Q3 25
0.62×
Q2 25
0.54×
Q1 25
0.48×
Q4 24
0.43×
0.78×
Q3 24
0.40×
Q2 24
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LUNG
LUNG
UNTY
UNTY
Operating Cash FlowLast quarter
$44.9M
Free Cash FlowOCF − Capex
$44.3M
FCF MarginFCF / Revenue
125.7%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
2.90×
TTM Free Cash FlowTrailing 4 quarters
$81.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LUNG
LUNG
UNTY
UNTY
Q1 26
Q4 25
$-7.1M
$44.9M
Q3 25
$-8.2M
$45.5M
Q2 25
$-3.9M
$-25.3M
Q1 25
$-13.2M
$17.9M
Q4 24
$-6.7M
$48.0M
Q3 24
$-7.2M
$17.7M
Q2 24
$-5.8M
$-8.4M
Free Cash Flow
LUNG
LUNG
UNTY
UNTY
Q1 26
Q4 25
$-7.1M
$44.3M
Q3 25
$-8.3M
$45.3M
Q2 25
$-4.0M
$-25.5M
Q1 25
$-13.5M
$17.6M
Q4 24
$-6.8M
$47.3M
Q3 24
$-7.7M
$17.5M
Q2 24
$-6.2M
$-8.6M
FCF Margin
LUNG
LUNG
UNTY
UNTY
Q1 26
Q4 25
-31.4%
125.7%
Q3 25
-38.4%
138.1%
Q2 25
-16.6%
-74.2%
Q1 25
-60.0%
59.9%
Q4 24
-28.8%
166.5%
Q3 24
-37.6%
63.3%
Q2 24
-30.0%
-33.7%
Capex Intensity
LUNG
LUNG
UNTY
UNTY
Q1 26
Q4 25
0.1%
1.6%
Q3 25
0.4%
0.7%
Q2 25
0.2%
0.5%
Q1 25
1.3%
1.0%
Q4 24
0.5%
2.4%
Q3 24
2.0%
0.5%
Q2 24
2.3%
0.5%
Cash Conversion
LUNG
LUNG
UNTY
UNTY
Q1 26
Q4 25
2.90×
Q3 25
3.16×
Q2 25
-1.54×
Q1 25
1.54×
Q4 24
4.17×
Q3 24
1.62×
Q2 24
-0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons